Literature DB >> 20049543

Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner.

Rodolfo Núñez1, William D Erwin, Richard E Wendt, Anne Stachowiak, Martha Mar, Donna Stevens, John E Madewell, Henry W Yeung, Homer A Macapinlac.   

Abstract

INTRODUCTION: Single photon emission computed tomography/computed tomography (SPECT/CT) delivers in a single imaging modality the functional-metabolic information from the SPECT image, combined with the detailed anatomical information from a diagnostic quality CT scanner.
METHOD: In this review, we provide the details for the acquisition, processing, and display of the SPECT, as well as the CT, and the fused SPECT/CT images, with one of the newest devices that combines a dual-headed gamma camera with a multislice CT scanner. Also, we go over the performance characteristics, including the planning and installation requirements for this type of scanners. In addition, we describe what are the current and feasible near-future applications of this new and exciting hybrid imaging modality. DISCUSSION: The ability to combine an optimized state-of-the-art SPECT image, with resolutions down to 5 mm, with a diagnostic quality CT image-using slices as thin as 1.25 mm-provides a diagnostic advantage that potentially can deliver a more convenient and faster diagnosis, with clinical implications in a significant percentage of patients. This imaging technique has been investigated in a wide range of studies for the oncologic patient, including but not limited to bone scintigraphy, (111)In-pentetreotide scintigraphy, lymphoscintigraphy, (67)Ga and labeled leukocyte infection imaging, (131)I-metaiodobenzylguanidine, parathyroid scintigraphy, (131)I diagnostic scintigraphy, and (111)In ProstaScint, and for planning of radionuclide therapy.
CONCLUSION: Therefore, this evolving and exciting imaging modality will continue to grow and define its place as an integral part of the evaluation of the cancer patient.

Entities:  

Mesh:

Year:  2010        PMID: 20049543     DOI: 10.1007/s11307-009-0266-4

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  52 in total

Review 1.  Functional-anatomical image fusion in neuroendocrine tumors.

Authors:  Orazio Schillaci
Journal:  Cancer Biother Radiopharm       Date:  2004-02       Impact factor: 3.099

2.  Comparison of methods of attenuation and scatter correction in brain perfusion SPECT.

Authors:  Masuo Hayashi; Jun Deguchi; Keita Utsunomiya; Makoto Yamada; Tsuyoshi Komori; Masayasu Takeuchi; Kensei Kanna; Isamu Narabayashi
Journal:  J Nucl Med Technol       Date:  2005-12

3.  Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma.

Authors:  Harri Keski-Säntti; Sorjo Mätzke; Tomi Kauppinen; Jyrki Törnwall; Timo Atula
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-08       Impact factor: 2.503

Review 4.  Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations.

Authors:  Michael K O'Connor; Brad J Kemp
Journal:  Semin Nucl Med       Date:  2006-10       Impact factor: 4.446

5.  Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma.

Authors:  Avi Khafif; Shlomo Schneebaum; Dan M Fliss; Hedva Lerman; U Metser; Rami Ben-Yosef; Ziv Gil; Leonor Reider-Trejo; Livshitz Genadi; Einat Even-Sapir
Journal:  Head Neck       Date:  2006-10       Impact factor: 3.147

6.  Procedure guideline for hepatic and splenic imaging. Society of Nuclear Medicine.

Authors:  H D Royal; M L Brown; D E Drum; C E Nagle; J M Sylvester; H A Ziessman
Journal:  J Nucl Med       Date:  1998-06       Impact factor: 10.057

7.  Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.

Authors:  Michael Gabriel; Florian Hausler; Reto Bale; Roy Moncayo; Clemens Decristoforo; Peter Kovacs; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

8.  Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

Authors:  M J Manyak; G H Hinkle; J O Olsen; R P Chiaccherini; A W Partin; S Piantadosi; J K Burgers; J H Texter; C E Neal; J A Libertino; G L Wright; R T Maguire
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

Review 9.  Single-photon emission computed tomography/computed tomography in abdominal diseases.

Authors:  Orazio Schillaci; Luca Filippi; Roberta Danieli; Giovanni Simonetti
Journal:  Semin Nucl Med       Date:  2007-01       Impact factor: 4.446

10.  Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.

Authors:  K Tharp; O Israel; J Hausmann; L Bettman; W H Martin; M Daitzchman; M P Sandler; D Delbeke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

View more
  3 in total

1.  Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine.

Authors:  Peeyush Bhargava; Guocheng He; Amin Samarghandi; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 2.  Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?

Authors:  Giovanni Luca Gravina; Vincenzo Tombolini; Mario Di Staso; Pietro Franzese; Pierluigi Bonfili; Antonio Gennarelli; Leda Di Nicola; Carlo Masciocchi; Ernesto Di Cesare
Journal:  Eur Radiol       Date:  2012-07-14       Impact factor: 5.315

3.  Role of SPECT and SPECT/CT in the Surgical Treatment of Primary Hyperparathyroidism.

Authors:  Michele L Taubman; Melanie Goldfarb; John I Lew
Journal:  Int J Mol Imaging       Date:  2011-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.